Invacare recalls DOLOMITE GLOSS rollators (models 450-680) due to seat collapse risk. Affected units have serial numbers 20BHL0002-21IHL1910. Stop using immediately to prevent injury.
Premature failure of the seat during use, the plastic eyelets of the folding mechanism of the device's seat can break, and in a worst-case crossbar also breaks and the Rollator can collapse causing injury to user
Take action
Contact the company
📍Recalling firmInvacare Corporation1200 Taylor St · Elyria, OH 44035-6248
“Invacare DOLOMITE GLOSS Rollator Recall: Seat Collapse Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/57844-invacare-dolomite-gloss-rollator-recall-seat-collapse-risk. Based on FDA recall #Z-2445-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2445-2023%22&limit=1).
The FDA announced on June 15, 2023, that Invacare Corporation is recalling DOLOMITE GLOSS Rollators due to the risk of collapse. The hazard involves premature failure of the seat's plastic eyelets and crossbar, which can cause injury to users.
The plastic eyelets of the folding mechanism of the device's seat can break. In a worst-case scenario, the crossbar also breaks and the Rollator collapses, causing injury to the user.
Context
GovInfoNow's records show Invacare Corporation has 6 other recalls on record since November 16, 2018. Other recent recalls of similar products include Bard THORA/ PARA TRAY Recall: Lidocaine Ampoules Risk (May 21, 2026), PALACOS R+G pro 40/80 Dental Cement Recall: Ampoule Breakage Risk (December 9, 2025), and PALACOS MV+G pro 40/80 Dental Cement Recall: Ampoule Breakage Risk (December 9, 2025).
How to tell if you have this one
Check for serial numbers between 20BHL0002 and 21IHL1910 on the rollator. The affected models include DOLOMITE GLOSS 450, 520, 600, and 680 rollators.
Brand
Invacare
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Stop using it now
Immediately stop using the rollator if it has a serial number between 20BHL0002 and 21IHL1910.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “US Nationwide distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 2 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-2445-2023 (June 15, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2445-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.